Skip to main content
TipRanks
Go Ultimate75% OFF

InspireMD (NSPR) Stock Forecast & Price Target

710 Followers
See the Price Targets and Ratings of:

NSPR Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to InspireMD in the past 3 months

NSPR Stock 12 Month Forecast

$3.50▲(352.20% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for InspireMD in the last 3 months. The average price target is $3.50 with a high forecast of $4.00 and a low forecast of $3.00. The average price target represents a 352.20% change from the last price of $0.77.
Highest Price Target$4.00Average Price Target$3.50Lowest Price Target$3.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for NSPR
Price TargetArticle
Lake Street$4buy416.80%UpsideReiterated09/22/26
Maxim Group$4→$3buy287.60%UpsideReiterated08/19/26
Piper Sandler$3buy287.60%UpsideReiterated07/31/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
DFTXDefinium Therapeutics
RDNTRadnet
AXGNAxoGen
PLSEPulse Biosciences
AHCOAdaptHealth

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering InspireMD

3 Months
Adam Maeder
Adam MaederPiper Sandler
Success Rate2/8 ratings generated profit
25%
Average Return
-2.76%

Copying Adam Maeder's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -2.76% per trade.

1 Year
Adam Maeder
Adam MaederPiper Sandler
Success Rate2/8 ratings generated profit
25%
Average Return
-25.55%

Copying Adam Maeder's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -25.55% per trade.

2 Years
Adam Maeder
Adam MaederPiper Sandler
Success Rate2/8 ratings generated profit
25%
Average Return
-39.24%

Copying Adam Maeder's trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -39.24% per trade.

NSPR Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for NSPR
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy65431
Buy00000
Hold00000
Sell00000
Strong Sell00000
total65431

In the current month, NSPR has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NSPR average Analyst price target in the past 3 months is 3.50.

NSPR Financial Forecast

$-2$-1.5$-1$-0.5$0Q1 2026Q3 2026Q4 2026
High$-0.11
Consensus$-0.13
Low$-0.14

NSPR Earnings Forecast

Next quarter’s earnings estimate for NSPR is -$0.13 with a range of -$0.14 to -$0.11. The previous quarter’s EPS was -$0.12. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$1.8M$2.2M$2.6M$3M$3.4MQ1 2026Q3 2026Q4 2026
High$3M
Consensus$2.65M
Low$2.3M

NSPR Sales Forecast

Next quarter’s sales forecast for NSPR is $2.65M with a range of $2.30M to $3.00M. The previous quarter’s sales results were $2.24M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

NSPR Stock Forecast FAQ

What is NSPR’s average 12-month price target, according to analysts?
Based on analyst ratings, InspireMD’s 12-month average price target is $3.50.
What is NSPR’s upside potential, based on the analysts’ average price target?
InspireMD has 352.20% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NSPR a Buy, Sell or Hold?
InspireMD has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is InspireMD’s price target?
The average price target for InspireMD is $3.50. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $4.00, the lowest forecast is $3.00. The average price target represents a 352.20% increase from the current price of $0.774.
What do analysts say about InspireMD?
InspireMD’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of NSPR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.